The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

The suicide trigger no one is talking about

Last week jolted us with a double shock.

First came the suicide of venerated designer Kate Spade at just 55, fast followed by that of celebrated chef, author, and traveling TV personality Anthony Bourdain at 61.

Both seemed to have it all… fame, fortune, and (in Bourdain’s case especially) a lives of adventure well worth living.

If these recent events teach us anything, it’s that all of us are vulnerable to life-altering moments that can knock us down. And some folks just aren’t able to get up again.

Right before news of Bourdain’s death, the CDC released a report detailing how suicide rates in the U.S. have steadily been rising in nearly every state – now a whopping 30 percent higher than they were in 1999.

The official tally of suicides in the U.S. during 2016 alone totaled 45,000.

And, of course, TV doctors are now appearing in droves to talk about depression, bipolar disorder, and the importance of being diagnosed and getting on the right drugs ASAP.

But it turns out that this could do more harm than good, because there’s one cause of this ongoing tragedy that’s not being given the spotlight it deserves – even though the evidence has been clear for a quite a while now.

I’m not just referring to antidepressants, which have long been linked to suicidal behavior. There’s a list of drugs as long as your arm that are known to have caused people of all ages to do the unthinkable, and recognizing the symptoms of drug-induced depression could, in fact, save your life.

A pharmaceutical nightmare

While we focus on suicide whenever celebrities are the victims, most of the lives cut short by it belong to everyday people.

Douglas Briggs, for example, was a family doctor from North Carolina who took his own life at 54. Only 37 years old, a Minnesota man named Woody Witcza hanged himself from the rafters in his garage. Then, there was Cody Miller, a high-school athlete from upstate New York who was just 15 when he knotted a noose around his neck.

While those are only three names, there are many, many more victims of this heartbreaking epidemic who all had something in common: They were taking drugs that are believed to be directly responsible for their suicides.

Cody had been given the allergy drug Singulair. Douglas was taking the epilepsy med Neurontin to treat back pain. And Woody was prescribed the antidepressant Zoloft… not because he was depressed, but because he couldn’t fall asleep at night.

And this isn’t some far-fetched idea that greedy lawyers have come up with so they can sue drugmakers. It’s been acknowledged (even by the FDA!) for a very long time that there are a wide variety of drugs that can cause depression and “suicidal thinking.” And we’re learning about new ones all the time.

Take Singulair, for example. It doesn’t even seem possible that a drug dispensed for a stuffy nose and itchy eyes could cause “agitation,” “depression,” “disorientation,” “hallucinations,” and “suicidal thinking and behavior (including suicide)” — all FDA-mandated warnings on the box.

So, let’s say you’ve got allergies… but the meds you take for them make you depressed. Just pop a mood med, right?

Not so fast — because antidepressants like the Zoloft that Woody took are known for the ability to tip the scales for anyone who might have suicidal tendencies, children and adolescents in particular.

Another drug called Siliq, OK’d by the FDA just last year for the treatment of psoriasis, has been called a “suicide stunner” by one expert because of the numbers of self-inflicted deaths that occurred during its early trials. In fact, it came out of the gate with a black-box warning for suicide “ideation and behavior.”

Then, of course, there’s the widely advertised stop-smoking med Chantix. The FDA is sitting on hundreds of reports of suicides related to Chantix, as well as almost 2,000 attempted ones — yet the agency allowed Pfizer to strip the black-box warning about “serious neuropsychiatric events” from the packaging last year.

Drugmaker Roche has attempted to dance around the suicide issue for its anti-viral flu med Tamiflu (now also available as a generic), which comes with warnings on the label about “abnormal behavior” that in some cases can have “fatal outcomes.”

Those “outcomes,” however, have included a 16-year-old boy who hanged himself last year soon after starting up on the drug. And over a decade ago, it was implicated in the suicides of 12 children in Japan.

Other meds that can trigger depression (which is known to significantly up the risk of suicide)  include beta-blockers for high blood pressure, steroids, and a drug used to treat cancer and viral infections called interferon alfa, which is said to cause depression in up to 40 percent of patients.

But that’s only the beginning. A report done by UK scientists in 2014 identified 110 different drugs linked to a risk of depression, which frequently goes hand-in-hand with an attempt at suicide. And there are likely a whole bunch more.

With so many meds associated with suicidal behavior, taking any drug is almost a crapshoot when it comes to how it can affect your mind.

There are, however, some warning signs to watch out for, such as:

  • Any episodes of depression that coincide with starting up – or stopping – a med. It can happen quickly… or months later.
  • Adverse mental effects that can crop up when your dose has been upped, even if you’ve been taking a drug for a long time.

And depression in seniors, especially ones who are isolated from family members, can be particularly brutal. A recently published study found that simply being up in years is a “consistent and important risk factor” for major depression. And getting effective treatment also gets more difficult the older you are.

Please remember, if you become depressed for any reason, never, ever try to go it on your own. Talk to a trusted friend or relative or call the national Suicide Prevention Lifeline, available 24/7 at 800-273-8255.

“US suicide rates increased more than 25% since 1999, CDC says” Susan Scutti, June 8, 2018, CNN, cnn.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.